The Therapeutic Goods Administration (TGA) has issued one infringement notice of $2,664 to a Sydney based individual for alleged unlawful importation of unregistered anaesthetic products.
It is alleged that the individual imported Bupivacaine Hydrochloride products into Australia which were not included in the Australian Register of Therapeutic Goods (ARTG) at the time of importation. Bupivacaine Hydrochloride is a prescription only medicine which can be used as a local anesthetic during surgical procedures.
The individual was previously a general practitioner but surrendered their registration in 2019 and did not have approval or authority to import the goods into Australia. The products were seized at the border and will not be released.
In Australia, the inclusion of therapeutic goods in the ARTG, through the regulatory processes, is an important safeguard to help ensure the safety, quality and performance of products.
If you suspect non-compliance in relation to therapeutic goods, you can report illegal or questionable practices online to the TGA. The TGA encourages the reporting of suspected non-compliant advertising.
